Average Co-Inventor Count = 5.72
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China (5 from 43 patents)
2. Boe Technology Group Co., Ltd. (3 from 18,140 patents)
3. Hefei Boe Display Technology Co., Ltd. (3 from 120 patents)
4. Beijing Boe Technology Development Co., Ltd. (2 from 1,242 patents)
5. China University of Petroleum (2 from 406 patents)
6. Beijing Boe Health Technology Co., Ltd. (2 from 12 patents)
7. Chinese Academy of Sciences (1 from 3,086 patents)
8. China National Petroleum Corporation (1 from 79 patents)
9. Ieit Systems Co., Ltd. (1 from 6 patents)
10. Chinese Academy of Medical Sciences (114 patents)
14 patents:
1. 12373364 - Asynchronous FIFO read/write control method and system, and electronic device
2. 12217857 - Public event administrating system
3. 12204620 - Data processing method, user terminal and servers
4. 11506941 - Display panel and preparation method thereof
5. 11487151 - Liquid crystal display panel and display device
6. 11243441 - Display panel, display apparatus, method of fabricating display panel, and operating method of operating display panel
7. 10697277 - Simulation device and method for integrated evaluation experiment for sand control wellbore plugging and plugging removal
8. 10647690 - 2,3-epoxy succinyl derivative, preparation method and use thereof
9. 10611742 - 4-oxo-4,5-dihydrothiazole derivative, preparation method and use thereof
10. 10611852 - Insulin-lipid complex, preparation method therefor, and preparation thereof
11. 9725658 - Method of processing low-grade heavy oil
12. 9522891 - Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection
13. 9428496 - Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
14. 8846678 - Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection